When cells’ tiny differences have far-reaching implications
Alex Shalek’s technologies for single-cell RNA profiling can help dissect the cellular bases of complex diseases around the globe.
Alex Shalek’s technologies for single-cell RNA profiling can help dissect the cellular bases of complex diseases around the globe.
With particles that release their payloads at different times, one injection could provide multiple vaccine doses.
By tracing the steps of liver regrowth, MIT engineers hope to harness the liver’s regenerative abilities to help treat chronic disease.
Institute Professor honored for groundbreaking work in nucleic acid delivery and nanoparticles.
The five-year collaboration aims to accelerate the translation of breakthrough engineering and biology for human health.
Using this diagnostic, doctors could avoid prescribing antibiotics in cases where they won’t be effective.
Following the successful development of vaccines against Covid-19, scientists hope to deploy mRNA-based therapies to combat many other diseases.
Faculty members Angela Belcher, Pablo Jarillo-Herrero, and Ronitt Rubinfeld elected by peers for outstanding contributions to research.
The 2nd Annual Research Slam featured three-minute talks on cutting-edge research from across MIT in an engaging public showcase and competition.
Postdoc Digbijay Mahat became a cancer researcher to improve health care in Nepal, but the Covid-19 pandemic exposed additional resource disparities.
The protein subunit vaccine, which can be manufactured using engineered yeast, has shown promise in preclinical studies.
MIT senior Daniel Zhang aims to provide hope for young patients and support to young students.
A new analysis offers guidance on the size of nanoparticles that could be most effective at stopping internal bleeding.
Departments of Biology and Brain and Cognitive Sciences welcome new professors.
The technique can help predict a cell’s path over time, such as what type of cell it will become.